Similar articles

• Over-the-counter vaginal contraceptive and spermicide drug products containing nonoxynol 9; required labeling. Final rule.

  Food and Drug Administration, HHS. Food and Drug Administration, HHS. Fed Regist. 2007 Dec 19;72(243):71769-85. Fed Regist. 2007. PMID: 18159651
• Status of certain additional over-the-counter drug category II and III active ingredients. Final rule.

  Food and Drug Administration, HHS. Food and Drug Administration, HHS. Fed Regist. 2002 May 9;67(90):31123-5. Fed Regist. 2002. PMID: 12001971
• Over-the-counter human drugs; labeling requirements; final rule; technical amendment. Food and Drug Administration, HHS. Final rule; technical amendment.

  [No authors listed] [No authors listed] Fed Regist. 2000 Jan 3;65(1):7-9. Fed Regist. 2000. PMID: 11010625
• Vaginal contraceptives--a time for reappraisal?

  Belsky R. Belsky R. Popul Rep H. 1975 Jan;(3):37-55. Popul Rep H. 1975. PMID: 1089573 Review. No abstract available.
• An overview of over the counter drugs in pregnancy and lactation.

  Das BP, Joshi M, Pant CR. Das BP, et al. Kathmandu Univ Med J (KUMJ). 2006 Oct-Dec;4(4):545-51. Kathmandu Univ Med J (KUMJ). 2006. PMID: 18603972 Review.